515813-02-2 Usage
Description
(3-Bromo-4-Methyl-phenyl)-carbamic acid tert-butyl ester, also known as bromomethylphenyl carbamic acid tert-butyl ester, is a chemical compound with the molecular formula C12H16BrNO2. It is a white to off-white crystalline powder with a molecular weight of 291.17 g/mol. (3-BroMo-4-Methyl-phenyl)-carbaMic acid tert-butyl ester is insoluble in water but soluble in most organic solvents. The tert-butyl ester group makes it more stable and resistant to hydrolysis under basic conditions, making it important for its role in organic synthesis and pharmaceutical research.
Uses
Used in Pharmaceutical Industry:
(3-Bromo-4-Methyl-phenyl)-carbamic acid tert-butyl ester is used as an intermediate in the synthesis of pharmaceuticals for its stability and resistance to hydrolysis under basic conditions. Its unique structure allows it to be a key component in the development of new drugs.
Used in Agrochemical Industry:
(3-Bromo-4-Methyl-phenyl)-carbamic acid tert-butyl ester is used as an intermediate in the synthesis of agrochemicals, contributing to the development of effective pesticides and other agricultural products. Its properties make it suitable for use in this industry, enhancing crop protection and yield.
Check Digit Verification of cas no
The CAS Registry Mumber 515813-02-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,1,5,8,1 and 3 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 515813-02:
(8*5)+(7*1)+(6*5)+(5*8)+(4*1)+(3*3)+(2*0)+(1*2)=132
132 % 10 = 2
So 515813-02-2 is a valid CAS Registry Number.
515813-02-2Relevant articles and documents
NEW FYN AND VEGFR2 KINASE INHIBITORS
-
Page/Page column 32, (2021/06/22)
The invention relates to a N-phenylcarbamoyl compound of Formula (I) or a pharmaceutically acceptable salt thereof for use in the inhibition of at least one of tyrosine kinase selected from Fyn and VEGFR2 in the treatment of diseases and disorders involved with one or both kinases. (Formula)
Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity
Angell, Richard,Aston, Nicola M.,Bamborough, Paul,Buckton, Jacky B.,Cockerill, Stuart,deBoeck, Suzanne J.,Edwards, Chris D.,Holmes, Duncan S.,Jones, Katherine L.,Laine, Dramane I.,Patel, Shila,Smee, Penny A.,Smith, Kathryn J.,Somers, Don O.,Walker, Ann L.
scheme or table, p. 4428 - 4432 (2009/04/06)
The biphenyl amides (BPAs) are a novel series of p38α MAP kinase inhibitor. The optimisation of the series to give compounds that are potent in an in vivo disease model is discussed. SAR is presented and rationalised with reference to the crystallographic binding mode.
NOVEL BIAROMATIC COMPOUNDS THAT ACTIVATE PPAR TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
-
Page/Page column 46; 47, (2010/10/20)
The invention relates to novel biaromatic compounds that correspond to the general formula (I) and also to the method for preparing them, and to their use in pharmaceutical compositions for use in human or veterinary medicine (in dermatology, and also in the field of cardiovascular diseases, immune diseases and/or lipid metabolism-related diseases), or alternatively in cosmetic compositions.
